Almon Einat Brill Insider Trades

Insider Trading History

Track insider trading activity for Almon Einat Brill. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Svp, Chief Development Officer
Holding Value $396k 196,995 shares
Last Trade
Jun 07, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$707k 196,995 shares
$3.59
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Svp, Product Development
Holding Value $1.41M 700,000 shares
Last Trade
Sep 13, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.57M 700,000 shares
$5.10
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Svp, Product Development
Holding Value $503k 250,000 shares
Last Trade
Mar 23, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.3M 250,000 shares
$17.20
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Svp, Product Development
Holding Value $372k 185,000 shares
Last Trade
Jul 16, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.6M 185,000 shares
$57.20
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Svp, Product Development
Holding Value $0 0 shares
Last Trade
May 02, 2012 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.7M 166,848 shares
$70.10
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Svp, Product Development
Holding Value $335k 166,848 shares
Last Trade
May 02, 2012 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11.7M 166,848 shares
$70.10
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Svp, Product Development
Holding Value $0 0 shares
Last Trade
May 02, 2012 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11.7M 166,848 shares
$70.10
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Product Development
Holding Value $0 0 shares
Last Trade
Oct 06, 2010 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.65M 70,000 shares
$95.00
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Product Development
Holding Value $235k 116,848 shares
Last Trade
Oct 06, 2010 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.65M 70,000 shares
$95.00
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Product Development
Holding Value $0 0 shares
Last Trade
Oct 06, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.43M 15,000 shares
$95.00
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Product Development
Holding Value $0 0 shares
Last Trade
Oct 05, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.82M 20,000 shares
$91.00
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Product Development
Holding Value $0 0 shares
Last Trade
Oct 04, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.17M 35,000 shares
$90.60
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Product Development
Holding Value $0 0 shares
Last Trade
Sep 07, 2010 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.09M 50,000 shares
$81.80
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Product Development
Holding Value $0 0 shares
Last Trade
Sep 07, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.84M 22,500 shares
$81.80
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Product Development
Holding Value $376k 186,848 shares
Last Trade
Sep 07, 2010 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.09M 50,000 shares
$81.80
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Product Development
Holding Value $0 0 shares
Last Trade
Sep 03, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.23M 27,500 shares
$81.10
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Product Development
Holding Value $261k 130,000 shares
Last Trade
Feb 25, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.93M 130,000 shares
$68.70
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Product Development
Holding Value $0 0 shares
Last Trade
Oct 19, 2009 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$375k 3,954 shares
$94.80
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Product Development
Holding Value $0 0 shares
Last Trade
Oct 19, 2009 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.91M 93,954 shares
$94.80
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Product Development
Holding Value $0 0 shares
Last Trade
Oct 19, 2009 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.63M 38,320 shares
$94.80
$2.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up